In addition, Yan et al. observed a link between FGL1 levels in circulating tumor cells and HCC tissues, indicating that patients with positive FGL1 expression tend to have higher TNM stages, distant metastases, and reduced postoperative survival [116]. This evidence concerns the gene FGL1 and hepatocellular carcinoma.